ertapenem has been researched along with Infections, Staphylococcal in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 5 (35.71) | 2.80 |
| Authors | Studies |
|---|---|
| Anjan, S; Bauerlein, JE; Breda, JR; Cardenas-Alvarez, JL; Ghodsizad, A; Loebe, M; Motoa, G; Munagala, MR; Natori, Y; Phancao, A; Simkins, J; Suarez, J; Thakkar-Rivera, N | 1 |
| Hayney, M; Rose, W; Sakoulas, G; Smelter, D | 1 |
| O'Neill, TJ; Pisani, B; Wilsey, HA | 1 |
| Bouchard, J; Edwards, L; Hitchins, M; O'Mara, K | 1 |
| Geriak, M; Haddad, F; Murray, BE; Nizet, V; Sakoulas, G; Singh, KV; Ulloa, ER | 1 |
| Graves, B; Hajkowicz, K; Paterson, DL; Stewart, A; Ta, K | 1 |
| Raut, A; Rybak, MJ; Smith, JR; Yim, J | 1 |
| Kumaraswamy, M; Nizet, V; Olson, J; Pogliano, J; Quach, DT; Rybak, MJ; Sakoulas, G; Singh, NB; Yim, J | 1 |
| Baker, MA; Cooper, MA; Li, J; Schneider, EK; Velkov, T; X Huang, J | 1 |
| Chen, CY; Huang, YB; Liao, FF | 1 |
| Gesser, RM; McCarroll, KA; Woods, GL | 1 |
| Ferguson, EC; Matthias, KR; Nix, DE | 1 |
| Batard, E; Bugnon, D; Caillon, J; Grossi, O; Jacqueline, C; Le Mabecque, V; Miegeville, AF; Potel, G | 1 |
| Bouziges, N; Jourdan, N; Lavigne, JP; Lemaire, X; Richard, JL; Sotto, A | 1 |
1 trial(s) available for ertapenem and Infections, Staphylococcal
| Article | Year |
|---|---|
Efficacy of ertapenem against methicillin-susceptible Staphylococcus aureus in complicated skin/skin structure infections: results of a double-blind clinical trial versus piperacillin-tazobactam.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Methicillin Resistance; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus | 2004 |
13 other study(ies) available for ertapenem and Infections, Staphylococcal
| Article | Year |
|---|---|
Cefazolin plus ertapenem and heart transplantation as salvage therapy for refractory LVAD infection due to methicillin-susceptible Staphylococcus aureus: A case series.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Ertapenem; Heart Transplantation; Heart-Assist Devices; Humans; Methicillin; Salvage Therapy; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Is the Success of Cefazolin plus Ertapenem in Methicillin-Susceptible Staphylococcus aureus Bacteremia Based on Release of Interleukin-1 Beta?
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Ertapenem; Humans; Interleukin-1beta; Methicillin; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Oxacillin plus ertapenem rapidly clears persistent left ventricular assist device-related methicillin-susceptible Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Ertapenem; Heart-Assist Devices; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Treatment of persistent methicillin-susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate.
Topics: Anti-Bacterial Agents; Bacteremia; Ertapenem; Humans; Infant, Newborn; Methicillin; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Oxacillin; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Ertapenem; Methicillin; Rats; Salvage Therapy; Staphylococcal Infections; Staphylococcus aureus | 2020 |
The Use of Therapeutic Drug Monitoring to Optimize Treatment of Carbapenem-Resistant Enterobacter Osteomyelitis.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Fosfomycin; Humans; Meropenem; Middle Aged; Osteomyelitis; Staphylococcal Infections; Staphylococcus epidermidis; Thienamycins | 2015 |
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Ceftaroline; Cephalosporins; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nafcillin; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Ertapenem; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcal Skin Infections | 2016 |
The Plasma Protein Binding Proteome of Ertapenem: A Novel Compound-Centric Proteomic Approach for Elucidating Drug-Plasma Protein Binding Interactions.
Topics: Anti-Bacterial Agents; beta-Lactams; Blood Proteins; Ertapenem; Humans; Models, Molecular; Protein Binding; Proteome; Proteomics; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Decrease in serum valproic acid levels during treatment with ertapenem.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cellulitis; Drug Antagonism; Ertapenem; Female; Humans; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Seizures; Staphylococcal Infections; Staphylococcus epidermidis; Valproic Acid | 2010 |
Effect of ertapenem protein binding on killing of bacteria.
Topics: Bacteria; beta-Lactams; Chromatography, High Pressure Liquid; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Humans; Indicators and Reagents; Kinetics; Lactams; Microbial Sensitivity Tests; Protein Binding; Regression Analysis; Spectrophotometry, Ultraviolet; Staphylococcal Infections; Staphylococcus aureus | 2004 |
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Infective Agents; beta-Lactams; Drug Synergism; Endocarditis, Bacterial; Ertapenem; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2006 |
[In vitro activity of ertapenem against strains isolated from diabetic foot infections].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Diabetic Foot; Drug Evaluation, Preclinical; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Inpatients; Microbial Sensitivity Tests; Species Specificity; Staphylococcal Infections | 2008 |